Aptevo Therapeutics (APVO) Shares Outstanding (2015 - 2026)
Aptevo Therapeutics (APVO) posted Shares Outstanding (Entity) of $1.2 million for Q1 2026, up 281.5% sequentially from $315535.0 in Q4 2025, and up 29607.63% YoY from N/an in Q1 2025.
Aptevo Therapeutics (APVO) Shares Outstanding (2015 - 2026) Analysis & Trends
Aptevo Therapeutics has reported Shares Outstanding (Entity) for 12 years, with the latest figure at $1.2 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 29607.63% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 29607.63% YoY) and the FY2025 annual result came in at $315535.0, up 41038.85% from the prior year.
- Shares Outstanding (Entity) advanced to $1.2 million in Q1 2026 per APVO's latest filing, from $315535.0 in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $1.2 million in Q1 2026 and troughed at $9.0 in Q1 2022.
- A 5-year average of $105372.9 and a median of $51.0 in 2024 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) gained 12.5% in 2022, then jumped 41038.85% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $9.0 in 2022, then soared by 133.33% to $21.0 in 2023, then surged by 3552.38% to $767.0 in 2024, then surged by 41038.85% to $315535.0 in 2025, then soared by 281.5% to $1.2 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $1.2 million, $315535.0, and $224965.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Aptevo Therapeutics | 3.18 Mn | -6.61 Mn | - | 1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.06 Mn |
| Dec 31, 2025 | 315,535.00 |
| Sep 30, 2025 | 224,965.00 |
| Jun 30, 2025 | 41,012.00 |
| Mar 31, 2025 | 4,052.00 |
| Dec 31, 2024 | 767.00 |
| Sep 30, 2024 | 792.00 |
| Jun 30, 2024 | 264.00 |
| Mar 31, 2024 | 52.00 |
| Dec 31, 2023 | 21.00 |
| Sep 30, 2023 | 21.00 |
| Jun 30, 2023 | 11.00 |
| Mar 31, 2023 | 12.00 |
| Dec 31, 2022 | 9.00 |
| Sep 30, 2022 | 9.00 |
| Jun 30, 2022 | 9.00 |
| Mar 31, 2022 | 8.00 |
| Dec 31, 2021 | 8.00 |
| Sep 30, 2021 | 8.00 |